THURSDAY, DECEMBER 8, 2016

NIAID researchers create blueprint for HIV prevention and treatment

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), have used evidence from three large clinical trials to develop a blueprint of prevention and treatment for HIV infections. Read More »

NIH encourages acceleration to eliminate AIDS

The National Institutes of Health (NIH) recently released statements in honor of World AIDS Day that encourage scientists to speed their efforts to eliminate AIDS as soon as possible. Read More »

Political leaders, Rotary officials continue efforts to eliminate polio worldwide

Leaders of Canada, Malta, Nigeria, Pakistan and the U.K. recently joined polio survivors in calling for the complete elimination of polio from the worldwide health scene. Read More »

Study shows Truvada disrupts HIV transmission for high-risk patients

Scientists recently conducted a study showing that HIV transmission may be prevented when people at high risk for the infection take Truvada. Read More »

WHO promotes expansion of antiretroviral therapy treatments to HIV patients

The World Health Organization (WHO) marked World AIDS Day on Tuesday by encouraging the expansion of antiretroviral therapy (ART) to all patients who have HIV. Read More »

Shortage of treatments counteract HIV efforts in Africa

Doctors Without Borders (MSF) recently stated that efforts to eliminate HIV in sub-Saharan Africa have been damaged by shortages of antiretroviral medicines needed for treatments. Read More »

Reduced HIV treatment costs allows UN to expand efforts

The United Nations Development Program (UNDP) has made significant decreases in the cost of HIV treatments, which has benefited patients in Equatorial Guinea, Haiti, Mali, South Sudan, Zambia and Zimbabwe. Read More »

Brain scans reveal cognitive deficits in older HIV patients

Using brain scans, Georgetown University Medical Center neuroscientists conducted a pilot study that showed cognitive deficits in older adults who have HIV. Read More »

Paragon Bioservices gains contract for HIV vaccine candidate

Paragon Bioservices, a biopharmaceuticals and vaccines manufacturer, recently gained a contract from the International AIDS Vaccine Initiative (IAVI) to create an HIV vaccine candidate. Read More »

Scientists use human DNA system to battle HIV infections

University of Saskatchewan scientists have discovered an ancient “error correction” system that is located inside the human genome and that may give the body some protection against HIV infections. Read More »

Sanofi introduces new packaging for Priftin

Sanofi recently introduced its new packing for Priftin (rifapentine) specially for treating latent tuberculosis infections (LTBI) in people who are 2 or older and have a high risk of developing tuberculosis (TB). Read More »

WHO releases resource for African adolescents with HIV

In honor of World AIDS Day on Dec. 1, the World Health Organization (WHO) published new guidelines that will help adolescents in Africa better understand their HIV infections and their special needs. Read More »

ViiV Healthcare strives to end mother-to-child HIV transmission

ViiV Healthcare recently used its Positive Action for Children Fund (PACF) to give grants to 34 new community-based organizations in 16 countries, all with the goal of ending mother-to-child HIV transmissions. Read More »

Pediatric group seeks better access to HIV/AIDS treatment for children

Leaders with the Global Pediatric Antiretroviral Commitment-to-Action recently introduced awards of public recognition that emphasize the need for improving accessibility to HIV/AIDS treatments for children. Read More »

Increased Ebola funding contributes to declines in other disease research

The eighth annual G-FINDER report shows that the worldwide investment funding Ebola research has resulted in a decline in efforts to create vaccines, drugs and diagnostics for other diseases that kill over 6 million people worldwide each year. Read More »

HIV/AIDS treatments shown to disrupt cognitive function

Antiretroviral medications that are commonly part of treatments for HIV infections and AIDS were recently proved to interrupt the function of insulation known as oligodendrocytes that protect the brain. Read More »

Brown study seeks information on African children who live with HIV-positive adults

A recent Brown University study shows that researchers have little knowledge about children who live with adults who have HIV infections in sub-Saharan Africa, even though these children are one of the most vulnerable populations in the area. Read More »

FIND and Janssen partner to fight tuberculosis

FIND and Janssen Pharmaceutical NV recently developed a new collaborative agreement to make tuberculosis (TB) diagnosis, treatment and care more accessible to patients around the world. Read More »

FIND teams with Cepheid to improve TB care in low- and middle-income countries

FIND and Cepheid have extended their partnership to include point-of-care tuberculosis (TB) diagnosis, which they intend to bring to health systems throughout low- and middle-income countries (LMIC). Read More »

Biotron develops combined HIV-1 and HCV treatment

Biotron Limited, which develops innovative treatments for viral diseases that have unmet medical needs, recently released information about its leading drug, a combined treatment for HIV-1 and Hepatitis C virus (HCV). Read More »